Triple assessment guideline for secondary care 2006 version

Download the Paper

Description: Triple assessment guideline for secondary care for the initial assessment of women with suspected breast cancer

Publet Introduction:
Guideline objectives
The application includes decision support for four areas crucial to the evaluation of a patient attending a triple assessment clinic (updated from the original workflow).
  • Genetic risk assessment.
    The application helps assess familial and genetic risk of breast cancer. The RAGs applet is used here to construct a pedigree and calculate genetic risk for the individual patient, expressed as high, medium or low. Support for this task is based on NHS NICE Familial Breast Cancer guidelines.
  • Selection of correct mode of imaging (mammography, ultrasound or neither). The medical knowledge for this task is derived mainly from ACR guidelines.
  • Selection of the right mode of biopsy (if any). The knowledge for this task is derived from NHSBSP guidelines.
  • Selection of the optimum way to manage the patient based on examination, imaging and cytology results (it is assumed that core biopsy results if any would not be available on same day). The knowledge for this task is derived mainly from BASO guidelines.
Target setting Secondary care
Target users Breast nurse practitioners, breast surgeons, breast radiologists, breast pathologists
Provenance 7.No provenance has been assigned (default value)
  • Author:
  • Release date: 20-07-2004 1:35:00
  • Status: Draft - Under Review
  • History:
Safety case
  • NICE (Familial Breast Cancer guidelines);
  • BASO (Management of symptomatic breast disease in the UK, 1998);
  • NCCN (Breast Cancer Screening and Diagnosis);
  • SIGN (Breast Cancer in Women);
  • ACR (Appropriate imaging work-up of palpable breast masses; Appropriate imaging work-up of breast microcalcifications; Performance of diagnostic mammography; Performance of a breast ultrasound examination);
  • ASCO (Breast cancer surveillance, 1998);
  • NHSBSP (Breast cancer screening assessment;
  • Non-operative diagnostic procedures and reporting in breast cancer screeni